Crohn's disease: Preserving inflammation-free phases
TECHNICAL UNIVERSITY OF MUNICH
Corporate Communications Center
This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35979/
High resolution images: https://mediatum.ub.tum.de/1543290
Early detection of Crohn's disease flare-ups leads to improved therapy options
Preserving inflammation-free phases
Crohn's disease is a chronic inflammatory disorder of the intestine that, in most cases, relapses episodically. As of now, there is no cure for this disease. A research group led by the Technical University of Munich (TUM) has discovered a marker at a microscopic level, which can be used to identify patients that show a high probability of suffering from an inflammation recurrence in the immediate future. With this insight, therapeutic counter-measures may be employed at an earlier stage.
Intestinal stem cell metabolism is facilitated by mitochondria - the in-cell power plants. Chronic inflammation processes inhibit the cells' metabolism and lead to functional loss of these stem cells.
In collaboration with the Helmholz Zentrum München and the Université de Paris, a TUM research team has discovered this connection by analyzing intestinal epithelial cells of Crohn's disease patients and comparing them to mouse model findings.
The interrelated role of stem cells and Paneth cells
Stem cells are indispensable for the maintenance and regeneration of tissues. Intestinal stem cells inside the intestines are intermingled with so-called Paneth cells, which are responsible for the local immune defense and for creating an environment in which the stem cells can prosper, thus termed guardians of the stem cell niche.
Patients suffering from Crohn's disease have fewer Paneth cells and furthermore, these are limited in their functionality. The research group examined the causes for alterations in Paneth cells and attempted to determine the importance of stem cell metabolism in this context.
In addition to mouse studies, the researchers analyzed intestinal biopsies from Crohn's disease patients, characterizing the stem cell niche meticulously. After six months, the patients' intestines were examined again endoscopically focusing on finding signs of inflammation.
Predicting Crohn's disease recurrence by observing the appearance of stem cells
The study showed that microscopic alterations in stem cell niche were particularly prevalent in those patients who showed symptoms of a relapse of inflammation after six months.
"These changes in the stem cell niche are a very early indicator for the start of inflammatory processes. Therefore, the appearance of the stem cell niche can be used to evaluate the probability of a disease recurrence after the resection of originally affected parts of the small intestine. This presents a reasonable starting point for therapeutic intervention," explained Dirk Haller, Professor for Nutrition and Immunology at TUM.
Restoring stem cell function
In both human patients and mouse models, alterations in Paneth and stem cells coincided with decreased mitochondria functionality.
Knowing that a lowered mitochondrial respiration leads to alterations in the stem cell niche, the researchers used dichloracetate (DCA), a substance applied in cancer therapy leading to an increase in mitochondrial respiration.
The shift in cellular metabolism induced by DCA was able to restore the intestinal stem cell functionality of mice suffering from inflammation, as demonstrated in intestinal organoids, organ-like structures cultured ex vivo.
Therapeutic approach for prolonging the inflammation-free phases of Crohn's disease
"These findings point to a new therapeutic approach for prolonging the inflammation-free remission phases of Crohn's disease," said Eva Rath, scientist at the TUM School of Life Sciences Weihenstephan and co-author of the study.
The aim of further research is to investigate the effect of DCA in animal models and patients in more detail. A so-called metabolic intervention - making targeted changes in the cells' metabolism - could prevent functional loss of stem cells and Paneth cells, which both maintain the intestinal barrier. This could lead to preventing subsequent inflammation.
Sevana Khaloian, Eva Rath, Nassim Hammoudi, Elisabeth Gleisinger, Andreas Blutke, Pieter Giesbertz, Emanuel Berger, Amira Metwaly, Nadine Waldschmitt, Matthieu Allez, Dirk Haller: Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence. Gut 2020;0:1-13. DOI:10.1136/gutjnl-2019-319514.
Dirk Haller, Professor for Nutrition and Immunology and Director of ZIEL - Institute for Food & Health, an interdisciplinary Central Institute of the Technical University of Munich.
The study is supported by the German Research Foundation (DFG) SFB 1371 and Priority Programme SPP 1656. The Helmsley Cheritable Trust (IBDOT).
Link to another article on the research of Prof. Haller's lab: The Microbiome - The mysterious ecosystem in our gut.
High resolution images: https://mediatum.ub.tum.de/1543290
Prof. Dr. Dirk Haller
Technical University of Munich
Tel.: +49 8161 71 2026
The Technical University of Munich (TUM) is one of Europe's leading research universities, with around 600 professors, 43,000 students, and 10,000 academic and non-academic staff. Its focus areas are the engineering sciences, natural sciences, life sciences and medicine, combined with economic and social sciences. TUM acts as an entrepreneurial university that promotes talents and creates value for society. In that it profits from having strong partners in science and industry. It is represented worldwide with the TUM Asia campus in Singapore as well as offices in Beijing, Brussels, Cairo, Mumbai, San Francisco, and São Paulo. Nobel Prize winners and inventors such as Rudolf Diesel, Carl von Linde, and Rudolf Mößbauer have done research at TUM. In 2006, 2012, and 2019 it won recognition as a German "Excellence University." In international rankings, TUM regularly places among the best universities in Germany. www.tum.de